Panel Discussion: Addressing Emerging Process Development & CMC Challenges Across the mRNA Landscape in CGT
- How are emerging mRNA modalities in CGT changing the biggest process development and CMC challenges teams need to solve today?
- Where are current analytical and control strategies falling short when applied across diverse mRNA-enabled CGT applications – and how should they evolve?
- What does a truly scalable and flexible CMC framework look like when supporting multiple mRNA-driven CGT modalities with differing requirements?